US2010189680A1PendingUtilityA1

Methods of Treating Various Cancers Using Melanoma Differentiating Associated Protein-7

Assignee: FISHER PAUL BPriority: Aug 16, 1996Filed: Aug 24, 2009Published: Jul 29, 2010
Est. expiryAug 16, 2016(expired)· nominal 20-yr term from priority
Inventors:Paul Fisher
A61P 35/02C12N 2710/10043C07K 14/47A61K 48/005Y10S435/81A61P 43/00A61K 48/00A61P 35/00A61K 38/1709A61K 31/16
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides a method for reversing the cancerous phenotype of a cancer cell by introducing a nucleic acid having the melanoma differentiation associated gene (mda-7) into the cell under conditions that permit the expression of the gene so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a method for reversing the cancerous phenotype of a cancer cell by introducing the gene product of the above-described gene into the cancerous cell so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a pharmaceutical composition having the melanoma differentiation associated gene (mda-7) or the gene product of the melanoma differentiation associated gene (mda-7) effective to reverse the cancerous phenotype of a cancer cell and a pharmaceutically acceptable carrier.

Claims

exact text as granted — not AI-modified
1 . A method for reversing a cancerous phenotype of a melanoma cell which comprises introducing a nucleic acid comprising a melanoma differentiation associated gene (mda-7) into the cell under conditions permitting the expression of the gene so as to thereby reverse the cancerous phenotype of the cell. 
   
   
       2 . A method of treating a melanoma in a subject comprising administering to the subject an effective amount of a nucleic acid comprising an mda-7 gene. 
   
   
       3 . A method of treating a melanoma in a subject comprising administering to the subject an effective amount of an mda-7 protein.

Join the waitlist — get patent alerts

Track US2010189680A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.